Abstract:Background: Deep brain stimulation (DBS) is a typical intervention treating drug-refractory dystonia. Currently, the selection of the better target, the GPi or STN, is debatable. The outcomes of DBS treating dystonia classified by body distribution and etiology is also a popular question. Objective: To comprehensively compare the efficacy, quality of life, mood, and adverse effects (AEs) of GPi-DBS vs. STN-DBS in dystonia as well as in specific types of dystonia classified by body distribution and etiology. Methods: PubMed, Embase, the Cochrane Library, and Google Scholar were searched to identify studies of GPi-DBS and STN-DBS in populations with dystonia. The efficacy, quality of life, mood, and adverse effects were quantitatively compared. Meta-regression analyses were also performed. This analysis has been registered in PROSPERO under the number CRD42020146145. Results: Thirty five studies were included in the main analysis, in which 319 patients underwent GPI-DBS and 113 patients underwent STN-DBS. The average follow-up duration was 12.48 months (range, 3-49 months). The GPI and STN groups were equivalent in terms of efficacy, quality of life, mood, and occurrence of AEs. The focal group demonstrated significantly better disability symptom improvement (P = 0.012) than the segmental and generalized groups but showed less SF-36 enhancement than the segmental group (P < 0.001). The primary groups exhibited significantly better movement and disability symptom improvements than the secondary non-hereditary group (P < 0.005), which demonstrated only disability symptom improvement compared with the secondary hereditary group (P < 0.005). The primary hereditary and idiopathic groups had a significantly lower frequency of AEs than the secondary non-hereditary group (P < 0.005). The correlation between disability symptom improvement and movement symptom improvement was also significant (P < 0.05). Conclusion: GPi-DBS and STN-DBS were both safe and resulted in excellent improvement in efficacy and quality of life in patients with dystonia. Compared with patients with segmental dystonia, patients with focal dystonia demonstrated better improvement in dystonia symptoms but less enhancement of quality of life. Those with primary dystonia had a better response to DBS in terms of efficacy than those with secondary dystonia. Patients who exhibit a significant improvement in movement symptoms might also exhibit excellent improvement in disability symptoms.

The role of genetics in the treatment of dystonia with deep brain stimulation: Systematic review and Meta-analysis

Surgicogenomics: The Role of Genetics in Deep Brain Stimulation in Parkinson's Disease Patients

Deep Brain Stimulation Treating Dystonia: A Systematic Review of Targets, Body Distributions and Etiology Classifications

Long‐Term Globus Pallidus Internus Deep Brain Stimulation in Pediatric Non‐Degenerative Dystonia: A Cohort Study and a Meta‐Analysis

The Efficacy And Predictors Of Using Gpi-Dbs To Treat Early-Onset Dystonia: An Individual Patient Analysis

Genetic Dystonias: Update on Classification and New Genetic Discoveries

Clinical and genetic profile of patients with dystonia: An experience from a tertiary neurology center from India

Deep brain stimulation in dystonia: The added value of neuropsychological assessments

Genetic Update and Treatment for Dystonia

1137 Prospective, Multicenter, International Registry of Deep Brain Stimulation for Dystonia: A Sub-analysis of Cervical Dystonia Patients

Experience of pallidal deep brain stimulation in dystonia at a tertiary care centre in India: An initial experience

Deep brain stimulation for treatment of pediatric dystonia

Recent Advances in the Genetics of Dystonia

Application of deep brain stimulation for the treatment of childhood-onset dystonia in patients with MEPAN syndrome

Deep brain stimulation for severe dystonia associated with Wilson disease: A prospective multicenter meta‐analysis of an N‐of‐1 trial

A Review on Response to Device-Aided Therapies Used in Monogenic Parkinsonism and GBA Variants Carriers: A Need for Guidelines and Comparative Studies

Deep Brain Stimulation in Parkinson Disease: A Switch for On/Off Dystonia

Predictive Factors of Outcome in Cervical Dystonia Following Deep Brain Stimulation: an Individual Patient Data Meta-Analysis.

New Perspectives of Deep Brain Stimulation Indications for Parkinson's Disease: A Critical Review

Toward adaptive deep brain stimulation for dystonia

Deep Brain Stimulation in Post-Traumatic Dystonia: A Case Series Study.